Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Progress in tuberculosis vaccine development.

Sven Baumann1, Ali Nasser Eddine, Stefan H E Kaufmann

  • 1Max Planck Institute for Infection Biology, Department of Immunology, Berlin, Germany.

Current Opinion in Immunology
|June 17, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Recreational Cannabis Use During Human Pregnancy: Its Effects on the Placenta and Endocannabinoid System.

International journal of molecular sciences·2026
Same author

GATA-3 localization shapes lymphocyte function.

Cell reports·2026
Same author

Modeling immune responses of cattle to <i>Mycobacterium bovis</i> using magnetic bioprinted granulomas.

mSphere·2025
Same author

Sex Differences in Vaccine-Induced Immunity and Protection Against Mycobacterium tuberculosis.

The Journal of infectious diseases·2025
Same author

The Paediatric BCG Vaccine Century: From Historical Success to Future Innovations.

Acta paediatrica (Oslo, Norway : 1992)·2025
Same author

Preliminary pharmacokinetic and psychophysical investigations after controlled oral and inhalative consumption of hexahydrocannabinol (HHC).

Scientific reports·2025
Same journal

Noncanonical ion channel signaling in neurovascular barrier regulation and immune cell trafficking.

Current opinion in immunology·2026
Same journal

A blind spot of human T cell immunology: epitope specificity in secondary lymphoid organs.

Current opinion in immunology·2026
Same journal

Germinal center responses at barrier organ sites.

Current opinion in immunology·2026
Same journal

Ocular sarcoidosis: from clinical signs to targeted interventions.

Current opinion in immunology·2026
Same journal

On or within: spatial determinants of antigen handling in the nasal turbinates.

Current opinion in immunology·2026
Same journal

Decoding the complexity of intestinal immunity with spatial transcriptomics.

Current opinion in immunology·2026
See all related articles

The first tuberculosis vaccine candidates are in clinical trials, with novel subunit and attenuated options showing promise. Continued research into immunology and microbiology will refine future tuberculosis vaccine design and efficacy assessment.

Area of Science:

  • Immunology
  • Microbiology
  • Vaccinology

Background:

  • The first tuberculosis (TB) vaccine candidates have advanced to clinical testing.
  • Novel subunit and viable attenuated vaccine candidates have completed preclinical development.
  • Existing BCG vaccination strategies require further enhancement.

Purpose of the Study:

  • To review advancements in TB vaccine development.
  • To explore novel immunological and microbiological findings relevant to vaccine design.
  • To identify potential biomarkers for assessing vaccine efficacy.

Main Methods:

  • Review of preclinical and early clinical data for TB vaccine candidates.
  • Analysis of recent discoveries in T-cell responses, including crosspriming.

Related Experiment Videos

  • Investigation of the roles of regulatory T cells and cytokines in immune responses.

    • Main Results:

    • Subunit and viable attenuated TB vaccine candidates have successfully completed preclinical stages.
    • Emerging research highlights the importance of crosspriming for potent T-cell responses.
    • Understanding T-cell dynamics and cytokine involvement is crucial for immune memory and migration.

    Conclusions:

    • Rational design of tuberculosis vaccines is an ongoing process.
    • Further insights into basic immunology and microbiology will drive improved vaccine development.
    • Knowledge gained can inform the creation of biomarkers to predict vaccine efficacy.